title: Amisulpride monotherapy may be a choice of maintenance treatment for patients with both bipolar I disorder and metabolic syndrome.
authors: Department of Family Medicine, Song-Shan Branch, Tri-Service General Hospital and School of Medicine, National Defense Medical Center, Taipei, Taiwan, ROC.
authors: Chung-Chih
authors: CC
authors: Hong
authors: Department of Psychiatry, Tri-Service General Hospital and School of Medicine, National Defense Medical Center, Taipei, Taiwan, ROC.
authors: Chih-Kang
authors: CK
authors: Chen
authors: Department of Psychiatry, Tri-Service General Hospital and School of Medicine, National Defense Medical Center, Taipei, Taiwan, ROC.
authors: Ta-Chuan
authors: TC
authors: Yeh
authors: Department of Psychiatry, Puli Branch, Taichung Veterans General Hospital, Taichung, Taiwan, ROC.
authors: Che-Sheng
authors: CS
authors: Chu
authors: Department of Psychiatry, Tri-Service General Hospital and School of Medicine, National Defense Medical Center, Taipei, Taiwan, ROC verducci@mail.ndmctsgh.edu.tw.
authors: Tien-Yu
authors: TY
authors: Chen
mesh_terms: D000077582:Amisulpride; D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D001714:Bipolar Disorder / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D008297:Male; D024821:Metabolic Syndrome / Q000150:complications / Q000188:drug therapy*; D013469:Sulpiride / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D055815:Young Adult
chemical_list: D014150:Antipsychotic Agents; D013469:Sulpiride; D000077582:Amisulpride